Skip to content
Tenfell
Awarded contract
Published 11 Aug 2023

DRUGS OF ABUSE AND POINT OF TESTING CARE (SBS 10241)

NHS Shared Business Services · United Kingdom

Key facts

Awarded
20 Jul 2023
Contract starts
08 Jun 2023
Contract ends
08 Jun 2027
Procedure
Open procedure (above threshold)
Buyer type
Health

Awarded to 14 suppliers

SupplierValue
Eurofins Forensic Services Limited—
IQVIA LTD—
Randox Laboratories—
SYNLAB Laboratory Services Limited—
Oscartech UK Ltd—
ABBOTT TOXICOLOGY LIMITED—
BHA Medical Limited—
Global Scientific Limited—
MATRIX DIAGNOSTICS LIMITED—
Nal Von Minden GmbH—
QUIDEL IRELAND LIMITED—
RAINBOW DIAGNOSTICS LTD—
ALPHA BIOLABORATORIES ANALYTICAL LTD—
Mornington 2000 LLP—

Description

NHS Shared Business Services act in an Agency capacity for and on behalf of its customers (Approved Organisations) - existing and new. These comprise of NHS and Social Care organisations (whether acting individually, or on behalf of, or together as members of any consortia) along with any other public or private sector bodies which NHS SBS authorises to use the resulting Framework. NHS Shared Business Services Limited (NHS SBS) has put in place a Framework Agreement for the provision of Goods and Services related to Drugs of Abuse and Point of Care Testing. The Framework Agreement includes 8 lots: Lot 1 - Rapid Drug Testing Kits Lot 2 - Back to Lab Testing Lot 3 - Pandemic Testing Lot 4 - Blood Borne Virus (BBV) and Liver Function Testing Lot 5 - Dried Blood Spot Drug & Alcohol Testing Lot 6 - Alcohol Testing Devices, including Breath Analysers, Continuous Monitoring and Associated Consumables Lot 7 - Operational Outsourcing of Services Lot 8 - Family Law Services

Categories (CPV)

Similar open tenders

About NHS Shared Business Services

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.